Patrick F Smith's most recent trade in Certara Inc was a trade of 5,409 Common Stock done at an average price of $11.0 . Disclosure was reported to the exchange on Oct. 7, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 07 Oct 2024 | 5,409 | 50,091 | - | 11.0 | 59,661 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 04 Oct 2024 | 7,151 | 57,242 | - | 0 | Common Stock | ||
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 04 Oct 2024 | 7,151 | 14,303 | - | - | Restricted Stock Units | ||
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 04 Oct 2024 | 1,742 | 55,500 | - | 11.0 | 19,145 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 02 Apr 2024 | 5,264 | 59,254 | - | 16.8 | 88,225 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 02 Apr 2024 | 4,740 | 50,513 | - | 16.8 | 79,490 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 02 Apr 2024 | 3,024 | 55,581 | - | 16.8 | 50,652 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 02 Apr 2024 | 649 | 58,605 | - | 17.7 | 11,500 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 02 Apr 2024 | 422 | 50,091 | - | 17.8 | 7,499 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 02 Apr 2024 | 328 | 55,253 | - | 17.7 | 5,796 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 01 Apr 2024 | 30,381 | 30,381 | - | - | Restricted Stock Units | ||
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 01 Apr 2024 | 8,646 | 62,089 | - | 0 | Common Stock | ||
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 01 Apr 2024 | 8,646 | 8,647 | - | - | Restricted Stock Units | ||
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 01 Apr 2024 | 7,852 | 67,208 | - | 0 | Common Stock | ||
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 01 Apr 2024 | 7,852 | 15,704 | - | - | Restricted Stock Units | ||
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 01 Apr 2024 | 2,733 | 59,356 | - | 17.9 | 48,866 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 01 Apr 2024 | 2,690 | 64,518 | - | 17.9 | 48,097 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 01 Apr 2024 | 1,532 | 53,443 | - | 17.9 | 27,392 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 20 Feb 2024 | 5,000 | 54,975 | - | 18 | 90,000 | Common Stock | |
| Certara Inc | Smith F Patrick | PRESIDENT, DRUG DEV SOLUTIONS | 05 Oct 2023 | 21,454 | 21,454 | - | - | Restricted Stock Units | ||
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 05 Jun 2023 | 19,104 | 59,975 | - | 21.5 | 411,691 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 31 Mar 2023 | 23,556 | 23,556 | - | - | Restricted Stock Units | ||
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 31 Mar 2023 | 8,646 | 81,973 | - | 0 | Common Stock | ||
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 31 Mar 2023 | 8,646 | 17,293 | - | - | Restricted Stock Units | ||
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 31 Mar 2023 | 2,894 | 79,079 | - | 23.8 | 68,877 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 31 Mar 2023 | 1,532 | 73,327 | - | 23.8 | 36,462 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 09 Nov 2022 | 2,387 | 74,859 | - | 13.5 | 32,177 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 01 Nov 2022 | 1,244 | 77,246 | - | 12.2 | 15,214 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 16 Aug 2022 | 10,000 | 78,490 | - | 17.7 | 177,100 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 08 Jun 2022 | 10,000 | 88,490 | - | 19.2 | 191,600 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 01 Apr 2022 | 25,939 | 25,939 | - | - | Restricted Stock Units | ||
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 01 Apr 2022 | 3,352 | 98,490 | - | 22.3 | 74,716 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 01 Apr 2022 | 1,532 | 101,842 | - | 21.5 | 32,907 | Common Stock | |
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 01 Nov 2021 | 3,631 | 103,374 | - | 0 | Common Stock |